Integrated's positive diagnosis
Also on Wednesday, software diagnostics company Integrated Research Limited (ASX: IRI) released first-half FY17 earnings guidance. For the six-month period, the company said it expects to report revenue between $42.3 million and $44.0 million, up from the $39.4 million the previous year. The company advised the market that it expects net profit after tax (NPAT) will be between $7.2 million and $8.0 million, versus $6.2 million in 1HFY16. We expect Integrated Research to deliver substantial earnings growth into FY18 driven by new contract wins and licence renewals. Shares in Integrated Research closed up 10.1% for the week. We own IRI as a research-driven investment in WAM Capital and WAM Research.
3 stocks mentioned
Wilson Asset Management has a track record of making a difference for shareholders and the community for more than 20 years. As the investment manager for eight leading LICs – WAM Capital (ASX: WAM), WAM Leaders (ASX: WLE), WAM Global (ASX: WGB),...